These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 34283812)
1. PLA2G4A promotes right-sided colorectal cancer progression by inducing CD39+γδ Treg polarization. Zhan Y; Zheng L; Liu J; Hu D; Wang J; Liu K; Guo J; Zhang T; Kong D JCI Insight; 2021 Aug; 6(16):. PubMed ID: 34283812 [TBL] [Abstract][Full Text] [Related]
2. NKp46-expressing human gut-resident intraepithelial Vδ1 T cell subpopulation exhibits high antitumor activity against colorectal cancer. Mikulak J; Oriolo F; Bruni E; Roberto A; Colombo FS; Villa A; Bosticardo M; Bortolomai I; Lo Presti E; Meraviglia S; Dieli F; Vetrano S; Danese S; Della Bella S; Carvello MM; Sacchi M; Cugini G; Colombo G; Klinger M; Spaggiari P; Roncalli M; Prinz I; Ravens S; di Lorenzo B; Marcenaro E; Silva-Santos B; Spinelli A; Mavilio D JCI Insight; 2019 Dec; 4(24):. PubMed ID: 31689241 [TBL] [Abstract][Full Text] [Related]
3. ST2 and regulatory T cells in the colorectal adenoma/carcinoma microenvironment: implications for diseases progression and prognosis. Cui G; Yuan A; Li Z; Goll R; Florholmen J Sci Rep; 2020 Apr; 10(1):5892. PubMed ID: 32246094 [TBL] [Abstract][Full Text] [Related]
4. Decreased Frequency of Intestinal CD39 Libera J; Wittner M; Kantowski M; Woost R; Eberhard JM; de Heer J; Reher D; Huber S; Haag F; Schulze Zur Wiesch J Front Immunol; 2020; 11():567472. PubMed ID: 33072107 [TBL] [Abstract][Full Text] [Related]
5. γδ T Cells: Unexpected Regulators of Cancer Development and Progression. Fleming C; Morrissey S; Cai Y; Yan J Trends Cancer; 2017 Aug; 3(8):561-570. PubMed ID: 28780933 [TBL] [Abstract][Full Text] [Related]
6. Immune Effects of γδ T Cells in Colorectal Cancer: A Review. Ma R; Yuan D; Guo Y; Yan R; Li K Front Immunol; 2020; 11():1600. PubMed ID: 33013819 [TBL] [Abstract][Full Text] [Related]
7. Progress of research on γδ T cells in colorectal cancer (Review). Pan L; Zhou Y; Kuang Y; Wang C; Wang W; Hu X; Chen X Oncol Rep; 2024 Dec; 52(6):. PubMed ID: 39364743 [TBL] [Abstract][Full Text] [Related]
8. The Dual Roles of Human γδ T Cells: Anti-Tumor or Tumor-Promoting. Li Y; Li G; Zhang J; Wu X; Chen X Front Immunol; 2020; 11():619954. PubMed ID: 33664732 [TBL] [Abstract][Full Text] [Related]
9. TCR-Vγδ usage distinguishes protumor from antitumor intestinal γδ T cell subsets. Reis BS; Darcy PW; Khan IZ; Moon CS; Kornberg AE; Schneider VS; Alvarez Y; Eleso O; Zhu C; Schernthanner M; Lockhart A; Reed A; Bortolatto J; Castro TBR; Bilate AM; Grivennikov S; Han AS; Mucida D Science; 2022 Jul; 377(6603):276-284. PubMed ID: 35857588 [TBL] [Abstract][Full Text] [Related]
10. Use of Tregs as a cell-based therapy via CD39 for benign prostate hyperplasia with inflammation. Jin X; Lin T; Yang G; Cai H; Tang B; Liao X; Li H; Chen X; Gong L; Xu H; Sun Y; Tan P; Yin J; Ma H; Ai J; Wang K; Wei Q; Yang L; Li H J Cell Mol Med; 2020 May; 24(9):5082-5096. PubMed ID: 32191396 [TBL] [Abstract][Full Text] [Related]
11. Significant and Conflicting Correlation of IL-9 With Niccolai E; Russo E; Baldi S; Ricci F; Nannini G; Pedone M; Stingo FC; Taddei A; Ringressi MN; Bechi P; Mengoni A; Fani R; Bacci G; Fagorzi C; Chiellini C; Prisco D; Ramazzotti M; Amedei A Front Immunol; 2020; 11():573158. PubMed ID: 33488574 [TBL] [Abstract][Full Text] [Related]
12. γδ T Cells for Leukemia Immunotherapy: New and Expanding Trends. Barros MS; de Araújo ND; Magalhães-Gama F; Pereira Ribeiro TL; Alves Hanna FS; Tarragô AM; Malheiro A; Costa AG Front Immunol; 2021; 12():729085. PubMed ID: 34630403 [TBL] [Abstract][Full Text] [Related]
13. FOXP3+ Tregs: heterogeneous phenotypes and conflicting impacts on survival outcomes in patients with colorectal cancer. Zhuo C; Xu Y; Ying M; Li Q; Huang L; Li D; Cai S; Li B Immunol Res; 2015 Mar; 61(3):338-47. PubMed ID: 25608795 [TBL] [Abstract][Full Text] [Related]
14. Reduced group IVA phospholipase A2 expression is associated with unfavorable outcome for patients with gastric cancer. Zhang X; Wu Q; Gan L; Yu GZ; Wang R; Wang ZS; Wang JJ; Wang X Med Oncol; 2013 Mar; 30(1):454. PubMed ID: 23307260 [TBL] [Abstract][Full Text] [Related]
15. Colorectal Cancer-Associated Immune Exhaustion Involves T and B Lymphocytes and Conventional NK Cells and Correlates With a Shorter Overall Survival. Sorrentino C; D'Antonio L; Fieni C; Ciummo SL; Di Carlo E Front Immunol; 2021; 12():778329. PubMed ID: 34975867 [TBL] [Abstract][Full Text] [Related]
16. Activated regulatory T-cells attenuate myocardial ischaemia/reperfusion injury through a CD39-dependent mechanism. Xia N; Jiao J; Tang TT; Lv BJ; Lu YZ; Wang KJ; Zhu ZF; Mao XB; Nie SF; Wang Q; Tu X; Xiao H; Liao YH; Shi GP; Cheng X Clin Sci (Lond); 2015 May; 128(10):679-93. PubMed ID: 25558978 [TBL] [Abstract][Full Text] [Related]
17. Interleukin-11-expressing fibroblasts have a unique gene signature correlated with poor prognosis of colorectal cancer. Nishina T; Deguchi Y; Ohshima D; Takeda W; Ohtsuka M; Shichino S; Ueha S; Yamazaki S; Kawauchi M; Nakamura E; Nishiyama C; Kojima Y; Adachi-Akahane S; Hasegawa M; Nakayama M; Oshima M; Yagita H; Shibuya K; Mikami T; Inohara N; Matsushima K; Tada N; Nakano H Nat Commun; 2021 Apr; 12(1):2281. PubMed ID: 33863879 [TBL] [Abstract][Full Text] [Related]
18. Targeting adenosine and regulatory T cells in cancer immunotherapy. Churov A; Zhulai G Hum Immunol; 2021 Apr; 82(4):270-278. PubMed ID: 33610376 [TBL] [Abstract][Full Text] [Related]
19. CD39+ regulatory T cells attenuate allergic airway inflammation. Li P; Gao Y; Cao J; Wang W; Chen Y; Zhang G; Robson SC; Wu Y; Yang J Clin Exp Allergy; 2015 Jun; 45(6):1126-37. PubMed ID: 25728362 [TBL] [Abstract][Full Text] [Related]
20. Spatial and single-cell colocalisation analysis reveals MDK-mediated immunosuppressive environment with regulatory T cells in colorectal carcinogenesis. Hashimoto M; Kojima Y; Sakamoto T; Ozato Y; Nakano Y; Abe T; Hosoda K; Saito H; Higuchi S; Hisamatsu Y; Toshima T; Yonemura Y; Masuda T; Hata T; Nagayama S; Kagawa K; Goto Y; Utou M; Gamachi A; Imamura K; Kuze Y; Zenkoh J; Suzuki A; Takahashi K; Niida A; Hirose H; Hayashi S; Koseki J; Fukuchi S; Murakami K; Yoshizumi T; Kadomatsu K; Tobo T; Oda Y; Uemura M; Eguchi H; Doki Y; Mori M; Oshima M; Shibata T; Suzuki Y; Shimamura T; Mimori K EBioMedicine; 2024 May; 103():105102. PubMed ID: 38614865 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]